Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Fitzal

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|March 2, 2025
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancerAriane Steindl, Clara Zach, Luzia Berchtold, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 14, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patientsKerstin Wimmer, Monika Sachet, Cristiano Ramos, et al.
Breast (Edinburgh, Scotland)|July 4, 2007
Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatmentMaria João Cardoso, Jaime Cardoso, Natália Amaral, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumabElisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Local Treatment of the Primary Tumor for Patients With Metastatic Cancer (PRIME-TX): A Meta-AnalysisJeffrey M Ryckman, Toms V Thomas, Ming Wang, et al.
Trials|December 6, 2018
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trialGuido Henke, Michael Knauer, Karin Ribi, et al.
Breast Care (Basel, Switzerland)|March 12, 2015
Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast CancerElisabeth Bergen, Anna S Berghoff, Margaretha Rudas, et al.
Breast (Edinburgh, Scotland)|February 22, 2025
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trialsKerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Breast Cancer Research and Treatment|January 25, 2024
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Cancer|May 4, 2018
Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysisAntonios Valachis, Eleftherios P Mamounas, Elizabeth A Mittendorf, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|March 2, 2025
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancerAriane Steindl, Clara Zach, Luzia Berchtold, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 14, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patientsKerstin Wimmer, Monika Sachet, Cristiano Ramos, et al.
Breast (Edinburgh, Scotland)|July 4, 2007
Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatmentMaria João Cardoso, Jaime Cardoso, Natália Amaral, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumabElisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Local Treatment of the Primary Tumor for Patients With Metastatic Cancer (PRIME-TX): A Meta-AnalysisJeffrey M Ryckman, Toms V Thomas, Ming Wang, et al.
Trials|December 6, 2018
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trialGuido Henke, Michael Knauer, Karin Ribi, et al.
Breast Care (Basel, Switzerland)|March 12, 2015
Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast CancerElisabeth Bergen, Anna S Berghoff, Margaretha Rudas, et al.
Breast (Edinburgh, Scotland)|February 22, 2025
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trialsKerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Breast Cancer Research and Treatment|January 25, 2024
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Cancer|May 4, 2018
Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysisAntonios Valachis, Eleftherios P Mamounas, Elizabeth A Mittendorf, et al.
Pageof 9